Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aleafia Health is a Canadian healthcare company focused on the medical cannabis market through a vertically integrated seed-to-patient model. The company operates a network of medical clinics under the Canabo Medical brand, which utilizes proprietary patient data to inform cannabinoid-based treatment plans. Its product portfolio includes oils, capsules, and sublingual strips marketed under brands such as Emblem and Kin Slips, targeting indications like chronic pain and insomnia. Aleafia also maintains a significant presence in the adult-use market with brands like Divvy and Bogart. Following a period of financial restructuring under the Companies' Creditors Arrangement Act, the company was acquired by SNDL Inc. in early 2024. The acquisition integrated Aleafia's medical distribution and cultivation assets into SNDL's broader cannabis portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aleafia Health.